Skip to main content
OpenTrials

Clinical trial condition

Primary Biliary Cholangitis

Explore clinical trials studying Primary Biliary Cholangitis. Study availability and eligibility vary by location and protocol.

51 public trials 15 recruiting studies
Refine in advanced search Browse all conditions

Primary Biliary Cholangitis trial results

Completed

ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)

NCT03602560

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Institute for Liver Health Chandler, Arizona, United States
  • Mayo Clinic Arizona - PPDS Phoenix, Arizona, United States
  • The Institute for Liver Health-Tucson Tucson, Arizona, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
View all 156 locations
View Trial Details
Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis

NCT03394924

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Digestive Health Specialists of the Southeast Dothan, Alabama, United States
  • Arkansas Diagnostic Center Little Rock, Arkansas, United States
  • Texas Clinical Research Institute Little Rock, Arkansas, United States
  • Southern California Research Center Coronado, California, United States
View all 86 locations
View Trial Details
Completed

A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of Tropifexor (LJN452) in PBC Patients

NCT02516605

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Novartis Investigative Site Rialto, California, United States
  • Novartis Investigative Site Miami, Florida, United States
  • Novartis Investigative Site Atlanta, Georgia, United States
  • Novartis Investigative Site Marietta, Georgia, United States
View all 28 locations
View Trial Details
Active, Not Recruiting

A Study of Elafibranor in Adult Japanese Participants With Primary Biliary Cholangitis (PBC)

NCT06730061

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Nippon Medical School - Chiba Hokusoh Hospital Chiba, Japan
  • Fukushima Medical University Hospital Fukushima, Japan
  • Chugoku Rosai Hospital Hiroshima, Japan
  • Teine Keijinkai Hospital Hokkaido, Japan
View all 16 locations
View Trial Details
Active, Not Recruiting

Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment.

NCT06247735

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • UA Thomas D. Boyer Liver Institute Tucson, Arizona, United States
  • Southern California Research Center - Coronado Coronado, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Velocity Clinical Research Santa Ana, California, United States
View all 38 locations
View Trial Details
Active, Not Recruiting

Open-Label Extension Study of Saroglitazar Magnesium in Participants With Primary Biliary Cholangitis

NCT06427395

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Zydus US013 Los Angeles, California, United States
  • Zydus US011 Pasadena, California, United States
  • Zydus US043 Sacramento, California, United States
  • Zydus US022 Aurora, Colorado, United States
View all 28 locations
View Trial Details
Active, Not Recruiting

Patients With Primary Biliary Cholangitis

NCT07573514

Conditions
Adenocarcinoma, Bile Duct Diseases, Biliary Tract Diseases, +20 more
Locations
  • Fondazione Policlinico Universitaro A. Gemelli IRCSS,UOC Medicina Interna e Gastroenterologia,Largo A. Gemelli, Roma, Italy
View Trial Details

Related conditions